J Clin Oncol 2015 Aug 20
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Related Questions
The patient is relatively asymptomatic.
New answer by Medical Oncologist at University of Nebraska Medical Center (October 12, 2018)
I do not change treatment based on just tumor markers in advanced breast cancer. When there is significant rise in the level of tumor markers, one should be following the pati...